|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.140 USD | +1.79% |
|
+7.55% | -31.74% |
| 07-13 | Lineage Cell Therapeutics, Inc. - Special Call | |
| 07-13 | Lineage Cell Therapeutics Provides Update On COR1 Cell Therapy Program For Corneal Endothelial Disease | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.79% | +7.55% | -15.56% | -21.92% | -31.74% | +18.82% | -19.15% | -55.81% | -65.35% | 284M | |
| +1.25% | -0.53% | -2.27% | +14.91% | +5.47% | +4.00% | +15.71% | -19.80% | +205.93% | 48.57B | |
| +1.98% | +9.05% | +4.26% | +34.03% | +147.71% | +413.94% | +532.17% | +598.65% | - | 41.95B | |
| +3.44% | -4.65% | +14.01% | +33.80% | +4.72% | +28.34% | +8.81% | -4.98% | +203.48% | 38.85B | |
| +1.40% | +0.10% | +10.04% | +10.10% | +7.81% | +6.61% | +61.93% | -2.49% | +1,136.43% | 37.24B | |
| +2.42% | +5.72% | +3.65% | +1.02% | +10.40% | +12.38% | +44.79% | -13.95% | +160.90% | 30.67B | |
| -0.16% | -3.11% | -11.04% | +8.40% | - | - | - | - | - | 16.1B | |
| +2.20% | +0.48% | +5.41% | +36.58% | +4.65% | +34.71% | +127.15% | +226.26% | - | 16.41B | |
| +0.89% | +2.39% | +2.24% | +17.07% | +12.56% | +8.73% | +19.62% | -37.70% | +84.77% | 13.97B | |
| +4.25% | -8.23% | -5.52% | +34.78% | -10.27% | -1.49% | -35.46% | -32.86% | +113.91% | 12.62B | |
| +11.36% | +11.04% | +13.02% | +40.63% | +30.70% | +55.66% | +26.01% | -36.41% | +204.15% | 12.56B | |
| -0.12% | -0.04% | +1.65% | +27.03% | +22.43% | +31.77% | -12.38% | -41.30% | +155.73% | 11.22B | |
| +0.82% | +1.29% | -14.74% | -0.27% | -8.72% | +79.28% | +566.87% | +298.19% | +2,369.66% | 10.86B | |
| +0.03% | +0.02% | +0.99% | +61.16% | +77.84% | +250.20% | +548.45% | - | - | 10.08B | |
| +0.10% | +7.36% | +35.14% | +36.34% | +40.56% | +34.05% | +36.06% | -61.52% | - | 9.86B | |
| -1.60% | +0.28% | -33.75% | -27.99% | -31.50% | +25.88% | +36.36% | +37.61% | +50.03% | 9.01B | |
| -0.90% | +0.33% | +4.61% | +23.38% | -11.38% | -20.22% | -17.62% | -28.77% | +34.29% | 8.68B | |
| +1.11% | +3.25% | +4.33% | +38.41% | +57.22% | +154.77% | +615.95% | +184.96% | - | 8.83B | |
| +2.95% | +9.69% | +0.22% | -4.22% | +8.31% | +567.98% | +2,116.88% | +44.48% | - | 8.9B | |
| +1.04% | +0.22% | -7.07% | +27.53% | +35.56% | +145.47% | +367.35% | +69.39% | - | 8.68B | |
| Average | +1.71% | +1.85% | +0.48% | +19.54% | +19.60% | +97.42% | +265.24% | +62.44% | +387.83% | 17.77B | |
| Weighted average by Cap. | +1.90% | +0.98% | +2.98% | +21.26% | +28.30% | +95.74% | +203.06% | +93.04% | +420.26% |
- Stock Market
- Stocks
- LCTX Stock
- Sector Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
